TNFRSF10A and rheumatoid arthritis: DR1 and DR4 Tg mice have also been used to test alternative treatments for RA, such as synthetic analog peptides, which contain substitutions in critical positions of the CII immunodominant epitope and suppress inflammatory arthritis by promoting regulatory T cell responses (172, 173).